Collectively, these findings suggested that elevated adropin in HF patients improves cardiac function by regulating metabolism and protecting the vascular endothelium; further, adropin has the potential to be a serum biomarker for early diagnosis of CVDs. This evidence concerns the gene ENHO and hydrops fetalis.